This combination of Chinese and Western drug therapy decreased the seizure severity and SRS frequency, markedly improved cognitive impairment and significantly decreased neuronal damage by up-regulating the expression of GDNF proteins and the level of Bcl-2/Bax in the hippocampal CA3 region. The gene discussed is BAX; the disease is Cognitive impairment.